Sign in
4

Changes in Ownership

Celldex Therapeutics, Inc. Filed Acc 0001415889-24-015950

SVP & GENERAL COUNSEL acquired 9,540 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jimenez Freddy A. SVP & GENERAL COUNSEL 2024-06-05 Option exercise +9,540 $10.38 $99,025 35,464 D
Derivatives
Jimenez Freddy A. SVP & GENERAL COUNSEL 2024-06-05 Option exercise · Incentive Stock Option (Right to Buy) −9,540 18,454 D
Loading xslF345X05/form4-06072024_080609.xml…